I was feeling every ounce of my chest cold, the thing everyone apparently has, the one that’s going around, the one that’s not covid but who could tell. I…
Wellness
Over the last 12 months, Revive Therapeutics (RVV.C) stock slipped 88% from $0.26 per share to a measly $0.03, but is Revive down for the count? Some analysts believe…
Hey y’all, Lucy Copperpot back for more analysis of Equity.Guru companies – this one is no longer on the client list, but I asked for permission to dig in…
Revive Therapeutics (RVV.C), a company that specializes in creating treatments and tests for diseases that don’t have many existing options available, has made a deal with a health research…
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the…
We have some 29 companies on our watchlist, all in a variety of sectors, that we’re covering at any one time. Some are clients, some not, some are on…
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl…
Continuing out Core Story program, today’s exploration is a company we just can’t get enough of, Medexus Pharmaceuticals (MDP.T). CEO Ken D’Entremont has nailed his milestones the last 18…
When you come to a stock pick website like this and see a random story that ;predicts a company will have great revenue growth going forward, hey, I get…
Element Nutritional Sciences (ELMT.C), a Canadian company focused on the development of patented and science-based consumer good products geared to men and women over the age of 50, announced…